Dawnrays Pharmaceutical (Holdings) logo

2348 - Dawnrays Pharmaceutical (Holdings) News Story

HK$1.08 0.0  0.9%

Last Trade - 1:46am

Sector
Healthcare
Size
Small Cap
Market Cap £158.3m
Enterprise Value £105.6m
Revenue £107.8m
Position in Universe 2246th / 5954

BRIEF-Dawnrays Pharmaceutical Says Cetirizine Hydrochloride Tablets 10Mg Granted Approval By NMPA

Thu 2nd January, 2020 2:03pm
Jan 2 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
 2348.HK :
    * CETIRIZINE HYDROCHLORIDE TABLETS 10MG GRANTED APPROVAL BY
NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Source text for Eikon:  ID:nHKSb2ghJ6 
Further company coverage:  2348.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.